Moderna CEO Bancel steps down as sales chief, Bloomberg News reports

Published 11/05/2024, 12:26 PM
Updated 11/05/2024, 12:49 PM
© Reuters. CEO of Moderna Stephane Bancel looks up at the session "State of the Pandemic" during the World Economic Forum (WEF) in Davos, Switzerland, January 18, 2023. REUTERS/Arnd Wiegmann/File Photo
MRNA
-

(Reuters) -Vaccine maker Moderna (NASDAQ:MRNA)'s chief executive officer Stephane Bancel will vacate his role as the company's chief commercial officer, Bloomberg News reported on Tuesday citing one person familiar with the matter.

The company's president Stephen Hoge will take charge of sales as well as medical and research affairs, according to the report.

© Reuters. CEO of Moderna Stephane Bancel looks up at the session

Bancel will remain in his role as Moderna's CEO, the report added. Moderna did not immediately respond to a Reuters request for comment.

Moderna had announced in December Bancel would head sales and marketing, and work directly with the company's commercial team, after then commercial officer Arpa Garay had decided to leave.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.